Geneos Wealth Management’s Research Frontiers REFR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-300
Closed 2469
2022
Q2
$0 Hold
300
﹤0.01% 2751
2022
Q1
$0 Buy
+300
New +$552 ﹤0.01% 2933
2020
Q3
Sell
-300
Closed -$1K 2681
2020
Q2
$1K Buy
+300
New +$1.11K ﹤0.01% 2497
2019
Q4
Sell
-300
Closed -$1K 2575
2019
Q3
$1K Buy
+300
New +$1.14K ﹤0.01% 2429
2016
Q3
Sell
-300
Closed -$1K 1990
2016
Q2
$1K Hold
300
﹤0.01% 1761
2016
Q1
$1K Buy
+300
New +$1.34K ﹤0.01% 1744

Other funds holding REFR

Geneos Wealth Management's REFR Position: Q3 2022 in Review

Geneos Wealth Management sold out of Research Frontiers (REFR) in Q3 2022, closing a stake of 300 shares.

Geneos Wealth Management first reported a position in REFR in Q1 2016 and held it in 6 quarters. The position peaked at $1K in Q2 2020. 26 funds tracked by Wall St. Rank hold REFR as of Q3 2022.

  • Geneos Wealth Management reported no remaining Research Frontiers position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 300 Research Frontiers shares in Q3 2022.
  • Geneos Wealth Management first reported a position in Research Frontiers in Q1 2016 and held it in 6 quarters.
  • Geneos Wealth Management's Research Frontiers position peaked at $1K in Q2 2020.
  • 26 funds tracked by Wall St. Rank held Research Frontiers as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.